1. Home
  2. PLAB vs BHVN Comparison

PLAB vs BHVN Comparison

Compare PLAB & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$28.84

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$14.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
BHVN
Founded
1969
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
PLAB
BHVN
Price
$28.84
$14.12
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$44.33
$29.08
AVG Volume (30 Days)
1.4M
3.6M
Earning Date
05-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
26.08
EPS
1.27
N/A
Revenue
$535,276,000.00
N/A
Revenue This Year
$6.70
N/A
Revenue Next Year
$4.96
N/A
P/E Ratio
$23.35
N/A
Revenue Growth
18.77
N/A
52 Week Low
$19.13
$7.48
52 Week High
$56.00
$18.57

Technical Indicators

Market Signals
Indicator
PLAB
BHVN
Relative Strength Index (RSI) 40.67 48.60
Support Level $27.61 $10.04
Resistance Level $35.04 $17.01
Average True Range (ATR) 1.39 0.97
MACD 0.38 -0.33
Stochastic Oscillator 27.13 0.31

Price Performance

Historical Comparison
PLAB
BHVN

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: